BRIEF published on 07/03/2024 at 12:38, 2 years 3 months ago Alpha Financial Markets Consulting PLC: Amendment to Form 8.3 Disclosure Shares Form 8.3 Disclosure Apex Fundrock Alpha Financial
BRIEF published on 07/03/2024 at 12:38, 2 years 3 months ago Alpha Financial Markets Consulting PLC : Modification du formulaire 8.3, Divulgation Actions Divulgation Formulaire 8.3 Apex Fonds Rocheux Alpha Financière
PRESS RELEASE published on 07/03/2024 at 12:33, 2 years 3 months ago Form 8.3 - Apex Fundrock Limited : AMENDMENT - FORM 8.3 - ALPHA FINANCIAL MARKETS CONSULTING PLC Chelverton Asset Management amends Form 8.3 disclosure for Apex Fundrock Limited relating to Alpha Financial Markets Consulting PLC shares holding Form 8.3 Apex Fundrock Limited Chelverton Asset Management Alpha Financial Markets Consulting PLC Disclosure Amendment
BRIEF published on 07/02/2024 at 13:27, 2 years 3 months ago Apex Fundrock Limited Discloses Position in Alpha Financial Markets Consulting plc Takeover Code Chelverton Asset Management Apex Fundrock Alpha Financial Stock Disclosures
BRIEF published on 07/02/2024 at 13:27, 2 years 3 months ago Apex Fundrock Limited divulgue une position dans Alpha Financial Markets Consulting plc Code De Reprise Gestion D'actifs Chelverton Apex Fonds Rocheux Alpha Financière Divulgations Boursières
PRESS RELEASE published on 07/02/2024 at 13:22, 2 years 3 months ago Form 8.3 - Apex Fundrock Limited : Re Alpha Financial Markets Consulting plc Chelverton Asset Management discloses ownership of 1.11% in Apex Fundrock Limited (MISL) per Form 8.3. Details of relevant securities holdings provided Form 8.3 Apex Fundrock Limited Chelverton Asset Management MISL Security Holdings
BRIEF published on 06/26/2024 at 11:56, 2 years 3 months ago Alpha Financial Markets Consulting: Apex Fundrock Limited Disclosure Securities Disclosure Apex Fundrock Alpha Financial Chelverton
BRIEF published on 06/26/2024 at 11:56, 2 years 3 months ago Alpha Financial Markets Consulting : Divulgation d'Apex Fundrock Limited Titres Divulgation Apex Fonds Rocheux Chelverton Alpha Financière
PRESS RELEASE published on 06/26/2024 at 11:51, 2 years 3 months ago Form 8.3 - Apex Fundrock Limited : Re Alpha Financial Market Consulting plc Chelverton Asset Management discloses a 1.45% interest in Apex Fundrock Limited. No other party disclosures reported Apex Fundrock Limited Chelverton Asset Management Disclosures 1.45% Interest Public Position Disclosure
BRIEF published on 05/24/2024 at 11:35, 2 years 4 months ago Disclosure of Interests by Chelverton Asset Management in Alpha Financial Market Consulting PLC Takeover Code Securities Disclosure Chelverton Asset Management Alpha Financial Market Consulting
Published on 10/23/2026 at 13:23, 2 hours 36 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 2 hours 59 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 2 hours 59 minutes ago First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 13 hours 39 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 16 hours 29 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/23/2026 at 15:40, 19 minutes ago Shanghai, Hamburg seek closer ties as friendship turns 40
Published on 10/23/2026 at 15:24, 34 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/23/2026 at 07:00, 8 hours 59 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 21 hours 59 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 21 hours 59 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 21 hours 59 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
